chenodeoxycholic acid has been researched along with Spastic Paraplegia, Hereditary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackstone, C; Chai, E; Chen, Z; Criscuolo, C; Fraidakis, MJ; Li, XJ; Mou, Y; Mukte, S; Nandi, G; Nielsen, JE; Nielsen, TT | 1 |
| Ferdinandusse, S; Vaz, FM | 1 |
1 review(s) available for chenodeoxycholic acid and Spastic Paraplegia, Hereditary
| Article | Year |
|---|---|
Bile acid analysis in human disorders of bile acid biosynthesis.
Topics: Adult; Animals; Chenodeoxycholic Acid; Cholestasis; Cholesterol; Cholic Acid; Enterohepatic Circulation; Homeostasis; Humans; Infant; Intestinal Mucosa; Intestines; Liver; Mass Spectrometry; Spastic Paraplegia, Hereditary; Zellweger Syndrome | 2017 |
1 other study(ies) available for chenodeoxycholic acid and Spastic Paraplegia, Hereditary
| Article | Year |
|---|---|
Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Humans; Induced Pluripotent Stem Cells; Neurons; Paraplegia; Spastic Paraplegia, Hereditary; Xanthomatosis, Cerebrotendinous | 2023 |